Marksans Pharma (formerly Glenmark Laboratories) is one of the fastest growing pharmaceuticals company in India, with a focused approach on creating a world class, global, fully integrated pharmaceutical company. Its manufacturing plant is one of the largest in Asia and is approved by UK-MCHRA and Australian-TGA authorities.

Marksans’ focus is to become a preferred supplier for formulation outsourcing by first world countries, develop a marketing presence in the EU and, through a combination of licensing and partnering, become a significant integrated pharmaceutical company. It has just completed the reverse takeover of TASC Pharmaceuticals, a publicly quoted API company, to form a corporation valued at $120 million.